Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study compared the efficacy of multimatrix mesalazine 2.4 g/day and 4.8 g/day with controlled-release mesalazine 2.25 g/day. METHODS: In this multicenter, randomized, double-blind study, 251 patients with mildly to moderately active ulcerative colitis received multimatrix mesal...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Intest Res
Main Authors: Ogata, Haruhiko, Yokoyama, Tadashi, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Format: Artigo
Jezik:Inglês
Izdano: Korean Association for the Study of Intestinal Diseases 2018
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5934598/
https://ncbi.nlm.nih.gov/pubmed/29743838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2018.16.2.255
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki